These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 9762782
1. Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients. Tötterman KJ, Huhti L, Sutinen E, Backman R, Pietinalho A, Falck M, Larsson P, Selroos O. Eur Respir J; 1998 Sep; 12(3):573-9. PubMed ID: 9762782 [Abstract] [Full Text] [Related]
2. Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction. Malolepszy J, Böszörményi Nagy G, Selroos O, Larsso P, Brander R. Eur Respir J; 2001 Dec; 18(6):928-34. PubMed ID: 11829098 [Abstract] [Full Text] [Related]
3. Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma. Ind PW, Villasante C, Shiner RJ, Pietinalho A, Böszörményi NG, Soliman S, Selroos O. Eur Respir J; 2002 Oct; 20(4):859-66. PubMed ID: 12412676 [Abstract] [Full Text] [Related]
4. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study. Ekström T, Ringdal N, Tukiainen P, Runnerström E, Soliman S. Ann Allergy Asthma Immunol; 1998 Sep; 81(3):225-30. PubMed ID: 9759798 [Abstract] [Full Text] [Related]
5. Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline. Kaae R, Agertoft L, Pedersen S, Nordvall SL, Pedroletti C, Bengtsson T, Johannes-Hellberg I, Rosenborg J. Br J Clin Pharmacol; 2004 Oct; 58(4):411-8. PubMed ID: 15373934 [Abstract] [Full Text] [Related]
6. Formoterol used as needed in patients with intermittent or mild persistent asthma. Chuchalin A, Kasl M, Bengtsson T, Nihlen U, Rosenborg J. Respir Med; 2005 Apr; 99(4):461-70. PubMed ID: 15763453 [Abstract] [Full Text] [Related]
7. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L. Drugs; 2006 Apr; 66(17):2235-54. PubMed ID: 17137405 [Abstract] [Full Text] [Related]
8. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients. Rosenborg J, Larsson P, Rott Z, Böcskei C, Poczi M, Juhász G. Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580 [Abstract] [Full Text] [Related]
9. Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis. Vilsvik J, Ankerst J, Palmqvist M, Persson G, Schaanning J, Schwabe G, Johansson A. Respir Med; 2001 Jun; 95(6):484-90. PubMed ID: 11421506 [Abstract] [Full Text] [Related]
10. Dose-related efficacy and safety of formoterol (Oxis) Turbuhaler compared with salmeterol Diskhaler in children with asthma. Pohunek P, Matulka M, Rybnícek O, Kopriva F, Honomichlová H, Svobodová T. Pediatr Allergy Immunol; 2004 Feb; 15(1):32-9. PubMed ID: 14998380 [Abstract] [Full Text] [Related]
11. A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients. Schreurs AJ, Sinninghe Damsté HE, de Graaff CS, Greefhorst AP. Eur Respir J; 1996 Aug; 9(8):1678-83. PubMed ID: 8866594 [Abstract] [Full Text] [Related]
12. Single-dose comparison of formoterol (Oxis) Turbuhaler 6 microg and formoterol Aerolizer 12 microg in moderate to severe asthma: a randomised, crossover study. Schlimmer P. Pulm Pharmacol Ther; 2002 Aug; 15(4):369-74. PubMed ID: 12220942 [Abstract] [Full Text] [Related]
13. Low-dose formoterol Turbuhaler (Oxis) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.). Ekström T, Ringdal N, Sobradillo V, Runnerström E, Soliman S. Respir Med; 1998 Aug; 92(8):1040-5. PubMed ID: 9893773 [Abstract] [Full Text] [Related]
14. Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Boonsawat W, Charoenratanakul S, Pothirat C, Sawanyawisuth K, Seearamroongruang T, Bengtsson T, Brander R, Selroos O. Respir Med; 2003 Sep; 97(9):1067-74. PubMed ID: 14509562 [Abstract] [Full Text] [Related]
15. Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics. Rosenborg J, Bengtsson T, Larsson P, Blomgren A, Persson G, Lötvall J. Eur J Clin Pharmacol; 2000 Aug; 56(5):363-70. PubMed ID: 11009043 [Abstract] [Full Text] [Related]
16. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C. Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189 [Abstract] [Full Text] [Related]
17. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline. Richter K, Janicki S, Jörres RA, Magnussen H. Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726 [Abstract] [Full Text] [Related]
18. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer. Lecaillon JB, Kaiser G, Palmisano M, Morgan J, Della Cioppa G. Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908 [Abstract] [Full Text] [Related]
19. Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients. Singh D, Piccinno A, Borrill Z, Poli G, Acerbi D, Meuleners L, Woodcock A. Pulm Pharmacol Ther; 2008 Apr; 21(3):551-7. PubMed ID: 18321744 [Abstract] [Full Text] [Related]
20. Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma. Ankerst J, Persson G, Weibull E. Pulm Pharmacol Ther; 2003 Apr; 16(3):147-51. PubMed ID: 12749830 [Abstract] [Full Text] [Related] Page: [Next] [New Search]